Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,978.50
-86.30 (-4.18%)
Aug 1, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 325.97 billion as of August 1, 2025. Its market cap has decreased by -1.13% in one year.
Market Cap
325.97B
Enterprise Value
299.59B
Revenue
56.17B
Ranking
n/a
PE Ratio
46.66
Stock Price
1,978.50
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 325.97B, an increase of 9.72%. That is a compound annual growth rate of 1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 340.19B | 16.05% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
| Nov 20, 2020 | 297.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,213.89B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 647.34B |
| Aurobindo Pharma | 627.15B |